Most recent update: Tuesday, December 10, 2019 - 11:08

Bariatric News - Cookies & privacy policy

You are here


USGI to launch ESSENTIAL endoscopic incisionless trial

USGI Medical has obtained conditional approval of its investigational device exemption (IDE) application from the FDA to launch what the company believes to be the largest multicentre, randomised, sham-controlled study of an endoscopic procedure for weight loss ever conducted. The company plans to enrol approximately 350 subjects at up to nine centres across the US in the ESSENTIAL trial.

Emerging bariatric technologies showcased at SAGES

Three next-generation devices showcased at this year’s meeting could offer gastrointestinal specialists options in the future for treating the obese patient. Promising clinical data revealed that a next-generation plication endoscopic stapler, as well as the Overstitch and TransPyloric Shuttle are safe and effective. Here, we take a closer look at the devices and the data…

Bariatric complications treated effectively by endoscopy

Endoscopy offers a less invasive approach and helps to treat many of the complications from bariatric surgery, according to Dr Matthew Kroh, Director of Surgical Endoscopy and Assistant Professor of Surgery at the Cleveland Clinic Lerner College of Medicine.

ASGE publishes initiative for endoscopic simulators

The American Society for Gastrointestinal Endoscopy (ASGE) has published an article addressing the use of endoscopy simulators for training.

ASGE claims the “Preservation and Incorporation of Valuable Endoscopic Innovations” (PIVI) initiative addresses the use of endoscopy simulators for training and assessing. This latest PIVI is one in a series of statements defining the diagnostic or therapeutic threshold that must be met for a technique or device to become considered appropriate for incorporation into clinical practice.

Non-Inva 2012

Although growing steadily, bariatric surgery still does not attract the majority of the obese population, despite a good level of information and shared opinions with the rest of the medical community. Peri-operative risks and adverse effects in the long run may explain some of this reluctance.

New endoscopic stent can lead to 100% EWL

The printed version of this article from issue 12 of Bariatric News incorrectly stated that the Full Sense device operates by directly stimulating the vagus nerve. It in fact operates by stimulating neuro and humoral elements to induce satiety. The article has been updated to reflect this.

A simple endoscopic stent is being developed which will be able to be fit in 10-15 minutes and can lead to startling rates of weight loss, claim its designers.

Endoscopic therapies

In a presentation on endoscopic therapy, Dr Christopher Thompson, Harvard Medical School, Boston, US, asked ‘Can obesity be treated using an endoscope?’ 

ASGE/ASMBS task force publishes EBT white paper

A joint task force from the American Society for Gastrointestinal Endoscopy (ASGE) and the American Society for Metabolic and Bariatric Surgery (ASMBS) has recently published a white paper concerning endoscopic bariatric therapies (EBTs). Specifically, the white paper is intended to provide a framework for, and a pathway towards, the development, investigation, and adoption of safe and effective EBTs.

Subscribe to RSS - endoscopic